13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SC Filed 2023-11-13 Event — SEC 0001193125-23-275275 →

AI DMI LLC → Disc Medicine, Inc. IRON

Stake: — Shares: —
Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 21/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: +0.0%
  • Passive Schedule 13G filer baseline
  • Elevated short days-to-cover (10.6 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
4 transactions
0 buys · 2 sales · 2 awards/exercises
Issuer Cluster
7 13D/G filings on this issuer
6 other filings besides this one
Filer Track Record
4 filings by this filer
3 other filings in the data moat
Short Interest · settle 2026-10-15
DTC 10.63
7,457,523 shares short · +2.6% vs prior

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-08-12 Yu Jonathan Yen-Wen officer Option exercise 804 $13.50 $11K
2026-08-12 Yu Jonathan Yen-Wen officer Sale 804 $82.64 $66K
2026-07-07 Yu Jonathan Yen-Wen officer Option exercise 100 $13.50 $1K
2026-07-07 Yu Jonathan Yen-Wen officer Sale 100 $82.50 $8K

Other 13D/G Filings on Disc Medicine, Inc.

FiledFormFilerStakeShares
2026-10-26 SCHEDULE 13D/A AI DMI LLC 6.60% 2,943,410 view →
2025-03-03 SCHEDULE AI DMI LLC 10.80% 3,762,507 view →
2024-06-20 SC AI DMI LLC — — view →
2024-06-20 SC ORBIMED ADVISORS LLC — — view →
2023-06-21 SC ORBIMED ADVISORS LLC — — view →
2023-06-20 SC ACCESS INDUSTRIES MANAGEMENT, LLC — — view →

Other Filings by AI DMI LLC

FiledFormIssuerStakeShares
2026-10-26 SCHEDULE 13D/A DISC MEDICINE, INC. 6.60% 2,943,410 view →
2025-03-03 SCHEDULE Disc Medicine, Inc. IRON 10.80% 3,762,507 view →
2024-06-20 SC Disc Medicine, Inc. IRON — — view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →